# US 2016/0354246 A1 · Patient interface for ophthalmologic diagnostic and interventional procedures

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354246 A1
- Document ID: US20160354246A1
- Status: Published application
- Kind: A1
- Application number: 15/242,348
- Filed: 2016-08-19
- Published: 2016-12-08
- Earliest claimed: 2011-10-21
- Assignees: Optimedica Corporation
- Applicants: Optimedica Corporation
- Inventors: Phillip Gooding; Michael Wiltberger; Christine Beltran; Jonathan Talamo
- Web page: https://patentgrep.com/patent/US20160354246A1

## CPC

- A61F 9/009: Auxiliary devices making contact with the eyeball and coupling in laser light, {e.g. goniolenses (apparatus for eye examination A61B3/0008)}
- A61B 3/0008: {provided with illuminating means (A61B3/117, A61B3/14 take precedence)}
- A61B 3/0025: {characterised by electronic signal processing, e.g. eye models}
- A61B 3/102: {for optical coherence tomography [OCT]}
- A61B 3/14: Arrangements specially adapted for eye photography
- A61B 90/39: {Markers, e.g. radio-opaque or breast lesions markers}
- A61F 9/00814: {Laser features or special beam parameters therefor}
- A61F 9/00825: {for photodisruption}
- A61F 9/0084: {Laser features or special beam parameters therefor}
- A61B 2090/3937: {Visible markers}
- A61B 2090/3979: {infrared}
- A61B 2090/3983: {Reference marker arrangements for use with image guided surgery}
- A61F 2009/00851: {Optical coherence topography [OCT]}
- A61F 2009/0087: {Lens}
- A61F 2009/00887: {Cataract}
- A61F 2009/00897: {Scanning mechanisms or algorithms}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

An ophthalmic system may comprise an imaging device having a field of view oriented toward the eye of the patient; a patient interface housing defining a passage therethrough, having a distal end coupled to one or more seals configured to be directly engaged with one or more surfaces of the eye of the patient, and wherein the proximal end is configured to be coupled to the patient workstation such that at least a portion of the field of view of the imaging device passes through the passage; and two or more registration fiducials coupled to the patient interface housing in a predetermined geometric configuration relative to the patient interface housing within the field of view of the imaging device such that they may be imaged by the imaging device in reference to predetermined geometric markers on the eye of the patient which may also be imaged by the imaging device.

## Claims

### Claim at position 1

1-27. (canceled)

### Claim 28

A method for ophthalmic intervention on an eye of a patient having temporary geometric markers thereon indicative of the orientation of an axis of the patient's eye, comprising:
a. imaging three or more registration fiducials in reference to the temporary geometric markers on the eye of the patient, the registration fiducials being formed on an inner annulus of a patient interface housing within a field of view of an imaging device capable of 3-dimensional imaging of the registration fiducials;
d. imaging the three or more registration fiducials formed on the inner annulus of the patient interface housing within the field of view of the imaging device such that it may be imaged by the imaging device, and
c. processing image data generated via the imaging device for the three more registration fiducials and the temporary geometric markers on the eye of the patient so as to determine a position, a pitch, a roll and a yaw of the patient interface device relative to the geometric markers.

### Claim 29 (depends on 28)

The method of claim 28, directing a treatment laser beam through a passage of the patient interface housing and into the eye of the patient.

### Claim 30 (depends on 29)

The method of claim 29, wherein the treatment laser beam creates a dielectric breakdown within a cataractous crystalline lens of the eye.

### Claim 31 (depends on 30)

The method of claim 30, wherein the treatment laser beam is a pulsed treatment beam with a pulse repetition rate between about 1 kHz and about 200 kHz.

### Claim 32 (depends on 30)

The method of claim 30, wherein the treatment laser beam has a wavelength between about 800 nm and about 1,100 nm.

### Claim 33 (depends on 30)

The method of claim 30, wherein the treatment laser beam is a pulsed treatment beam having a pulse energy between about 1 microjoule and about 1,000 microjoules.

### Claim 34 (depends on 30)

The method of claim 30, wherein the treatment laser beam is a pulsed treatment beam with a pulse duration between about 100 femtoseconds and about 10 picoseconds.

### Claim 35 (depends on 28)

The method of claim 28, directing an illumination radiation from an illumination source toward the eye of the patient.

### Claim 36 (depends on 35)

The method of claim 35, wherein the illumination source is configured to direct at least a portion of the illumination radiation through the passage of the patient interface housing.

### Claim 37 (depends on 35)

The method of claim 35, wherein at least a portion of the patient interface housing is translucent to the illumination radiation, and the method further comprising directing at least a portion of the illumination radiation across the translucent portion of the patient interface housing toward the eye of the patient.

### Claim 38 (depends on 35)

The method of claim 35, wherein the illumination radiation is infrared radiation.

### Claim 39 (depends on 38)

The method of claim 38, wherein the fiducials comprise one or more materials that fluoresce in infrared radiation.

### Claim 40 (depends on 38)

The method of claim 38, wherein the fiducials comprise one or more materials that highly contrast in infrared radiation relative to other surrounding materials.

### Claim 41 (depends on 38)

The method of claim 38, wherein the fiducials comprise one or more surface irregularities relative to other surrounding surfaces.

### Claim 42 (depends on 41)

The method of claim 41, wherein the one or more surface irregularities are selected from the group consisting of: a concave feature, a convex feature, a depressed edge, a depressed step, a projecting edge, a projecting step, and an intersection of lines.

### Claim 43 (depends on 35)

The method of claim 35, wherein the illumination radiation is visible light radiation.

### Claim 44 (depends on 43)

The method of claim 43, wherein the fiducials comprise one or more materials that highly contrast in visible light radiation relative to other surrounding materials.

### Claim 45 (depends on 44)

The method of claim 44, wherein the fiducials comprise one or more surface irregularities relative to other surrounding surfaces.

### Claim 46 (depends on 45)

The method of claim 45, wherein the one or more surface irregularities are selected from the group consisting of: a concave feature, a convex feature, a depressed edge, a depressed step, a projecting edge, a projecting step, and an intersection of lines.

### Claim 47 (depends on 28)

The method of claim 28, wherein the imaging device comprises an optical coherence tomography system configured to measure the coherence of radiation scattered into an interferometer from the field of view.

### Claim 48 (depends on 47)

The method of claim 47, wherein the fiducials comprise one or more surface irregularities relative to other surrounding surfaces.

### Claim 49 (depends on 48)

The method of claim 48, wherein the one or more surface irregularities are selected from the group consisting of: a concave feature, a convex feature, a depressed edge, a depressed step, a projecting edge, a projecting step, and an intersection of lines.

### Claim 50 (depends on 28)

The method of claim 28, wherein the first, second and third fiducials are positioned on the inner annulus adjacent a distal end of the patient interface housing, the distal end being coupled to one or more seals around a periphery of passage of the patient interface housing configured to be directly engaged with an exterior surface of the eye of the patient.

### Claim 51 (depends on 50)

The method of claim 50, wherein the first and second fiducials are positioned at opposite sides of the inner annulus and the third fiducial is positioned at 90 degrees from each of the first and second fiducial.

### Claim 52 (depends on 28)

The method of claim 28, further comprising:
processing the image data to determine a geometric relationship between an anatomical feature of the eye and the imaging device based on a geometric relationship between the two or more fiducials and the geometric markers.

### Claim 53 (depends on 52)

The method of claim 52, wherein the imaging device is an Optical Coherence Tomography imaging device.

### Claim 54 (depends on 52)

The method of claim 52, further comprising:
determining whether the orientation of patient interface device is at a predetermined orientation with respect to a feature of the eye.

### Claim 55 (depends on 28)

The method of claim 28, wherein the feature of the eye is a surface of the eye.
